Doximity 将来の成長
Future 基準チェック /26
Doximity利益と収益がそれぞれ年間8.8%と9.2%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に19.4% 10%なると予測されています。
主要情報
8.8%
収益成長率
10.0%
EPS成長率
Healthcare Services 収益成長 | 30.4% |
収益成長率 | 9.2% |
将来の株主資本利益率 | 19.4% |
アナリストカバレッジ | Good |
最終更新日 | 15 Nov 2024 |
今後の成長に関する最新情報
Recent updates
Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%
Nov 13Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?
Nov 02Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?
Oct 15Doximity: Downgrade To Hold On Valuation Concerns
Oct 03Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors
Sep 23There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump
Aug 18Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns
Aug 10Doximity Faces Slower Revenue Growth As R&D Costs May Rise
Jul 23Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?
Jul 23At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?
Jul 01Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking
Jun 09Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)
May 17Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal
May 04Doximity: Significant Upside Remains, But Not Until The Growth Story Returns
Apr 29With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For
Apr 16Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Mar 26Doximity: Rating Upgrade To Buy As Outlook Turns Positive
Feb 21We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit
Feb 15What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?
Feb 13Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan
Jan 16Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital
Jan 04Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price
Dec 14Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism
Nov 10Doximity: Adding Value Using AI But Faces Near-Term Risks
Nov 01Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?
Oct 30Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively
Sep 25Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook
Aug 24Doximity Earnings: Too Many Problems, Sell
Aug 09A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)
Jul 29Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching
Jul 09Doximity: Continue To See Positive Upside From Current Stock Level
Jul 05The Returns At Doximity (NYSE:DOCS) Aren't Growing
Jun 21Doximity: Digital Health Play With Strong Fundamentals
Jun 21A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Apr 07Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return
Mar 20Doximity: Good Business But Extremely Overvalued
Feb 18Doximity Q3 Earnings: Disappointing Results
Feb 10業績と収益の成長予測
日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
---|---|---|---|---|---|
3/31/2027 | 651 | 201 | 261 | 279 | 12 |
3/31/2026 | 592 | 175 | 251 | 260 | 17 |
3/31/2025 | 540 | 165 | 230 | 235 | 15 |
9/30/2024 | 517 | 174 | 217 | 224 | N/A |
6/30/2024 | 494 | 161 | 162 | 168 | N/A |
3/31/2024 | 475 | 148 | 178 | 184 | N/A |
12/31/2023 | 468 | 138 | 162 | 167 | N/A |
9/30/2023 | 448 | 123 | 160 | 165 | N/A |
6/30/2023 | 437 | 119 | 186 | 192 | N/A |
3/31/2023 | 419 | 113 | 173 | 180 | N/A |
12/31/2022 | 402 | 119 | 173 | 180 | N/A |
9/30/2022 | 384 | 141 | 151 | 159 | N/A |
6/30/2022 | 362 | 148 | 131 | 138 | N/A |
3/31/2022 | 344 | 133 | 121 | 127 | N/A |
12/31/2021 | 317 | 107 | 113 | 117 | N/A |
9/30/2021 | 277 | 57 | 110 | 114 | N/A |
6/30/2021 | 243 | 30 | 103 | 107 | N/A |
3/31/2021 | 207 | 22 | 78 | 83 | N/A |
12/31/2020 | 177 | 14 | 48 | 53 | N/A |
3/31/2020 | 116 | 11 | 22 | 26 | N/A |
3/31/2019 | 86 | 1 | 14 | 15 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: DOCSの予測収益成長率 (年間8.8% ) は 貯蓄率 ( 2.6% ) を上回っています。
収益対市場: DOCSの収益 ( 8.8% ) US市場 ( 15.3% ) よりも低い成長が予測されています。
高成長収益: DOCSの収益は増加すると予測されていますが、大幅には増加しません。
収益対市場: DOCSの収益 ( 9.2% ) US市場 ( 8.9% ) よりも速いペースで成長すると予測されています。
高い収益成長: DOCSの収益 ( 9.2% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: DOCSの 自己資本利益率 は、3年後には低くなると予測されています ( 19.4 %)。